Literature DB >> 28457408

Hepatic Transplants in Espirito Santo State, Brazil.

S S Lauer1, G P S Miguel2, I W de Abreu3, A B Stein3.   

Abstract

BACKGROUND: The Meridional Hospital Liver transplant unit is the only one active in all Espírito Santo State, Brazil, since 2004.
OBJECTIVE: The aim is to analyze data of the first 250 transplants performed by the team.
METHODS: This retrospective study reviewed files from patients transplanted in the Meridional Hospital from January 2005 to December 2015.
RESULTS: There were 250 liver transplants in 236 patients and 14 retransplants. 72.4% were male recipients, with average age of 51.1 years (1-70 years), and the main etiology was alcoholic cirrhosis (33.6% of the cases). Surgical reintervention occurred in 58 patients (include retransplantations) during the same hospitalization, with revision of homeostasis and retransplant as main indications. In the retransplant group, 73.3% of patients died within 2 months. Thrombosis of the hepatic artery was responsible for 40% of the indications for retransplant. The average time between first and second transplant was 223 days (median 14 days). Currently 152 of 236 patients are living, with 1-year life expectancy of approximately 71%. The mortality peak occurred from the immediate postoperative period to 2 months post-transplant (63.8% of the deaths). 32% of subjects did not need intraoperative blood transfusion. The average time of intensive care unit stay was of 8.52 days, and overall hospital stay was 21.7 (median 15 days).
CONCLUSION: Despite the logistic difficulties and lack of donors our unit, keep in advance with survival comparable to other national centers (68% to 74% in 1-year).
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28457408     DOI: 10.1016/j.transproceed.2017.01.060

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  1 in total

1.  SOFA in the first 24 hours as an outcome predictor of acute liver failure.

Authors:  Edison Moraes Rodrigues-Filho; Rogério Fernandes; Anderson Garcez
Journal:  Rev Bras Ter Intensiva       Date:  2018-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.